Mydecine Innovations Group Inc C.MYCO

Alternate Symbol(s): MYCOF

Healthcare Advertising Agencies

Mydecine Innovations Group Inc. is a Canada-based biotechnology company. The Company is engaged in developing medications and therapies to address mental health disorders, such as nicotine addiction and posttraumatic stress disorder (PTSD). The Company conducts research and development on second generation compounds in Canada with a focus on developing and commercializing psychedelic-inspired regulated medicines. The Company has two lead 3,4-Methylenedioxymethamphetamine (MDMA) candidates. The Company is channeling its MYCO-005, MYCO-006, and MYCO-007 families of patent-pending second-generation MDMA and Psilocybin analogs through Applied Pharmaceutical Innovation (API). It utilizes artificial intelligence (AI) and pharma research infrastructure at the University of Alberta to develop and manufacture new medications to make them accessible to the general public upon Health Canada and Food and Drug Administration (FDA) approval.

CSE:MYCO - Post by User

Mydecine Innovations Group Inc

Bullboard Posts

Comment by andrewkursaon Jan 04, 2018 1:24am

258 Views

Post# 27277542

RE:RE:RE:RE:People talking about insider selling...DO YOUR HOMEWORK

Don't be fooled. I owe over 300K shares of NF and I'm slightly down few K but we're going to make some money soon but with the power of houses pushing this thing down we must go under 20 cents. Don't panic just buy more and wait and hold . Big money is coming back. Just watch MGW was pushed to 30 cents few months ago and now currently at almost,2$ heading to 5 . NF will follow but first 15-18 cents . Don't ask my why I don't know. It's just market

Bullboard Posts

Canadian psychedelic stock to supply MDMA to Yale